Bedaquiline use in South Africa reveals a lifesaving policy in action.
MetadataShow full item record
- Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis.
- Authors: Tadolini M, Tiberi S, Migliori GB
- Issue date: 2018 May
- Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.
- Authors: Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E
- Issue date: 2018 Feb
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis.
- Authors: Yates TA
- Issue date: 2018 Dec
- Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
- Authors: Achar J, Hewison C, Cavalheiro AP, Skrahina A, Cajazeiro J, Nargiza P, Herboczek K, Rajabov AS, Hughes J, Ferlazzo G, Seddon JA, du Cros P
- Issue date: 2017 Oct
- Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries.
- Authors: Lu X, Smare C, Kambili C, El Khoury AC, Wolfson LJ
- Issue date: 2017 Jan 26